Urofollitropin and Human Menopausal Gonadotropin are both drugs that
promote functional maturation of follicles, which can increase a woman's chances
of getting pregnant. At the same time, there are certain differences between the
two in terms of drug components, indications, and adverse reactions. Patients
must take medication under the guidance of a doctor. See the introduction of
Human Menopausal Gonadotropin below.
Human Menopausal Gonadotropin: The main components of Human Menopausal
Gonadotropin are follicle hormone and luteinizing hormone, which can promote the
development and maturation of female follicles, and promote the secretion of
estrogen from the follicles, make the endometrium proliferate, and have a strong
ovulation-stimulating effect. Causes multiple follicles to develop at the same
time. It is often used for infertility caused by anovulation and in patients
with poor effect on clomiphene citrate. The main adverse reactions after use are
ovarian hyperstimulation syndrome, which is manifested as lower abdominal
discomfort and swelling, accompanied by abdominal pain, nausea, vomiting, and
ovarian enlargement. If the ovaries are overstimulated, chest tightness,
shortness of breath, decreased urine output, pleural effusion, ascites, etc. may
occur in severe cases;
The above is the relevant content summarized by the editor of Kangyuan
Company. If you want to know more, please continue to follow us. We will
regularly update you about Human chorionic gonadotropin, Human Menopausal
Gonadotropin supplier, Urofollitropin price, Urokinase manufacturer, and Hormone
API Manufacturer Related content, I hope to help you.